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Abstract Several studies have attempted to explain the high overall prevalence of polycystic ovary syndrome among women world-
wide (about 4–10%) despite its link to subfertile phenotypes. For this reason, it is considered an evolutionary paradox. In this review,
we show that several genetic loci associated with the disease differently modulate the reproductive parameters of men and women.
This observation suggests that such genetic variants lead to opposite effects in the two sexes in reproductive success. Intralocus sexual
conﬂict as a cause of the persistence polycystic ovary syndrome genotypes among humans is supported.
© 2016 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
KEYWORDS: evolution, gender, hyperandrogenic, metabolic, PCOS, sex-speciﬁc
Introduction
Polycystic ovary syndrome (PCOS) is the most common en-
docrine disorder in women of reproductive age (Conway et al.,
2014; Dumesic et al., 2015). The high prevalence worldwide
and the large negative effect on female fertility have focused
attention on this multifaceted disease. Even if the disease
impairs female fertility, its high global prevalence is still in-
creasing, representing an evolutionary paradox.
The complexity of PCOS is demonstrated by the absence
of agreement on the deﬁnition of the disease itself, as a con-
sequence of its heterogeneity and uncertain cause. It is mainly
characterized by ovulatory disturbances, hyperandrogenism
and polycystic ovarian changes (Dumesic et al., 2015). It is
also associated with defects in glucose homeostasis caused
by insulin resistance, which confers a signiﬁcantly increased
risk for type 2 diabetes (Hayes et al., 2015). The resulting
hyperinsulinaemia seems to contribute to ovulatory disfunction
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(Hayes et al., 2015). These clinical features in fact gener-
ate different phenotypes with ethnic variations.
We recently demonstrated that ethnic variations in women
with PCOS are linked to a genetic background derived from
genetic drift (Casarini and Brigante, 2014). Familial aggre-
gation and twin studies (Vink et al., 2006) has also shown a
signiﬁcant role of genetics in PCOS. Further genome-wide as-
sociation studies (GWAS) have identiﬁed some susceptibility
regions associated with PCOS (Chen et al., 2011; Shi et al.,
2012; Welt and Duran, 2014), which need to be deepened.
Moreover, PCOS GWAS loci contain extensive alterations in
methylation, resulting in different gene expression proﬁles,
with differences between clinical subtypes based on pres-
ence or absence of obesity (Jones et al., 2015).
As PCOS is a disease affecting only women, all the studies
cited above were conducted among women. Men, however,
should have a role in the maintenance of the genetic trait pre-
disposing to PCOS. The male sex hormone, testosterone, regu-
lates libido, genital organ development and secondary sexual
characteristics, such as muscles, beard, hair and voice timbre.
For this reason, androgenization of men increases their re-
productive potential and can be considered favourable from
an evolutionary point of view. The pro-fertility role of tes-
tosterone is not primarily related to an increase of spermato-
genesis. In fact, germ cells do not express androgen receptor
and the testosterone effect on them is mediated by Sertoli,
Leydig and interstitial cells (O’Hara and Smith, 2015). There-
fore, fertility is preserved as normal in oligozoospermic mice
lacking the androgen receptor in testis peritubular myoid cells
(Zhang et al., 2006). An important reproductive role of
androgenized phenotypes could, therefore, depend on higher
chances of ﬁnding a partner and having sexual intercourse.
Besides androgenization, women with PCOS have a worse
metabolic proﬁle, but the opposite is the case in men: an-
drogens seem to protect the male from metabolic disorders
(Grossmann, 2011). Indeed, low testosterone levels, to-
gether with low LH, are strongly associated with obesity and
the risk of developing metabolic syndrome in men (Antonio
et al., 2015).
With this in mind, we might explain why the human species
tends to preserve a genetic trait that impairs female fertil-
ity but improves the chances of male reproduction.
In this review the genetics behind PCOS is analysed from
an innovative perspective, looking for a different modula-
tion on reproductive parameters in men and women.
Disease’s genetic hot spot
Several genetic loci were found in association with PCOS in
women of Han Chinese ancestry (Chen et al., 2011; Shi et al.,
2012), but only a few of them were conﬁrmed in Caucasian
(Welt and Duran, 2014). This might be a result of the differ-
ent diagnostic criteria used, but does reveal the ethnicity-
related nature of the disease. The most signiﬁcant loci and
the phenotypical consequences linked to their most signiﬁ-
cant variants, in women and men, are brieﬂy described. The
online database PCOSKB (http://www.pcoskb.bicnirrh.res.in),
a collection of genes, diseases, and biochemical pathways as-
sociated with the disease (Joseph et al., 2016) (Table 1), was
used to further conﬁrm the relationship between PCOS genes
and phenotype, and their sex-related differences. As the large
volume of data do not permit extensive quotation of the origi-
nal papers, we refer to the database for the speciﬁc refer-
ences supporting the informations provided in the table.
DENND1A gene
DENND1A is a member of the connecdenn family and binds
to clathrin and clathrin adaptor protein-2, acting as guanine
nucleotide exchange factors for the early endosomal small
GTPase RAB35 (Marat and McPherson, 2010). Some single
nucleotide polymorphisms (SNPs) in this gene were associ-
ated with PCOS, at least in women of Chinese and European
ancestry (Chen et al., 2011; Goodarzi et al., 2012; Shi et al.,
2012; Welt et al., 2012). DENND1A overexpression results in
a PCOS-like phenotype of theca cells, characterized by in-
creased androgen biosynthesis (McAllister et al., 2014), re-
vealing that this gene may give a strong contribution to the
establishment of hyperandrogenic PCOS phenotypes. In Han
Chinese women with PCOS, DENND1A SNPs are also associ-
ated with endocrine and metabolic disturbances (Cui et al.,
2013). These studies suggest that DENND1A gene is a candi-
date marker for the disease, although some contradictory data
exist. In fact, no association was found between DENND1A and
PCOS in Bahraini Arab women (Gammoh et al., 2015), most
likely because compensatory metabolic mechanisms depend
on the genetic background. Moreover, no studies investigat-
ing the role of DENND1A gene SNPs in men have ben con-
ducted, so it is not possible to draw any conclusions about
the role of SNPs within this gene.
THADA gene
Some aberrations in the thyroid adenoma-associated (THADA)
gene were found in thyroid tumours (Drieschner et al., 2006;
Rippe et al., 2003). SNPs within the THADA gene were asso-
ciated with body-mass index (BMI), weight, type 2 diabetes,
obesity and metabolic syndrome in both men and women of
different ethnicity (Almawi et al., 2013; DeMenna et al., 2014;
Gupta et al., 2013). This is most likely caused by thyroid hor-
mones in the metabolic regulation. As metabolic distur-
bances are frequent in women with PCOS, SNPs in the THADA
gene were associated with the disease in Asians and Europe-
ans (Cui et al., 2013; Goodarzi et al., 2012). A possible link
between this gene and the phenotypic metabolic features of
the disease should be mediated by the alteration of pancre-
atic beta-cell function (Simonis-Bik et al., 2010).
LHCGR gene
The LH chorionic and gonadotropin receptor (LHCGR) plays
a key role in the control of development and reproduction,
regulating oestrogen production, progesterone synthesis and
ovulation in women, and testosterone production in men
(Ascoli et al., 2002). Several LHCGR SNPs were largely studied
in association with PCOS (Mutharasan et al., 2013; Welt and
Duran, 2014; Hayes et al., 2015) and other diseases, including
abnormal sexual differentiation and ovarian cancer (Choi and
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Smitz, 2014; Lee et al., 2015). Moreover, a LHCGR SNP
(rs4073366) is associated with a higher response to gonado-
trophins in women undergoing assisted reproduction tech-
niques, resulting in increased risk of ovarian hyperstimulation
syndrome (O’Brien et al., 2013). Also, inactivating muta-
tions or deletions of the LHCGR gene give rise to infertile or
subfertile phenotypes in both sexes, such as Leydig cell hy-
poplasia in men (Gromoll et al., 2000; Segaloff, 2009) and
oligomenorrhoea, amenorrhoea and empty follicle syndrome
in women (Arnhold et al., 2009; Bentov et al., 2012; Yariz
et al., 2011). Moreover, activating mutations of the LHCGR
gene cause gonadotrophin-independent precocious puberty
in men (Segaloff, 2009), but have no detectable effects in
women. If the early sexual development is considered as a
precocious start of fertile age, it could represent an evolu-
tionary advantage in men rather than in women. Therefore,
the LHCGR genotype could have a modulatory effect on the
reproductive features of both sexes.
Table 1 Polycystic ovary syndrome genes showing sex-related associations.
Gene
Features
Female Male Both sexes
DENND1A Hyperandrogenism
Menstrual cycle irregularity
PCOS
Tumours (endometrioid
adenocarcinoma)
THADA Hyperandrogenism
PCOS
LHCGR Anovulation
PCOS
Primary amenorrhoea
Tumours (endometrioid
adenocarcinoma, mammary gland)
Azoospermia
Hypogonadism
Pseudohermaphroditism
Tumours (Leydig cells)
Infertility
Tumours (adrenal
aldosterone-producing)
Virilization
FSHR Anovulation
Endometriosis
PCOS
Polycystic ovaries
Primary amenorrhoea
Tumours (ovarian epthelial)
Azoospermia Infertility
Precocious puberty
YAP1 PCOS
RAB5 PCOS
SUOX PCOS Sulphite oxidase deﬁciency
INSR Hyperandrogenism
PCOS
Tumours (ovarian epthelial,
pancreatic beta-cell)
Acanthosis nigricans
Autoimmunity
Diabetes mellitus
Dyslipidaemia
Fatty liver
Hypertension
Insulin sensitivity, insulin resistance
Myotonic dystrophy
Obesity
Rabson–Mendenhall syndrome
Retinopathy
Skin lesion
Werner syndrome
AR Primary amenorrhoea
Preeclampsia
Tumours (breast, ovarian
epithelial, endometrium,
extramammary Paget disease,
multiple metastatic,
Androgen insensitivity syndrome
Androgenetic alopecia
Azoospermia and oligozoospermia
Bone mineral density
Kennedy disease
Pseudoermaphroditism
Spermatogenesis impairment
Tumours (prostate, urothelial, bladder)
Infertility
Obesity
Tumours (skin appendage, salivary gland
and duct, sebaceous gland, benign
pleomorphic adenomas)
Virilization
PCOS, polycystic ovary syndrome.
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FSHR gene
The FSH receptor (FHSR) belongs to the superfamily of the
rhodopsine-like G protein-coupled receptors, together with
the LHCGR. It is a mediator of follicle maturation by regu-
lating the proliferation and differentiation of the ovarian cells
(Simoni et al., 1997), although in-vitro studies have demon-
strated the apoptotic potential of FSH exerted through its re-
ceptor in granulosa cells (Amsterdam et al., 1999). In men,
FSHR mediates the FSH-dependent maturation of germ cells.
FSHR gene carries the common SNPs c.2039A>G (rs6166) and
c.919A>G (rs6165), which are in strong linkage disequilib-
rium, resulting in two discrete isoforms largely widespread
among human populations (Simoni and Casarini, 2014). Several
studies have suggested that FSHR c.2039A>G is a modulator
of the ovarian response to FSH in women (Perez-Mayorga et al.,
2000) and spermatogenesis, testis volume and testosterone
levels in men (Grigorova et al., 2013; Lazaros et al., 2013;
Lindgren et al., 2012), affecting the FSH, inhibin B and anti-
Müllerian hormone serum levels (Grigorova et al., 2014; Hagen
et al., 2013). A recent in-vitro study conﬁrmed that this poly-
morphism results in themodulation of steroidogenesis in granu-
losa cells (Casarini and Brigante, 2014). Also, a SNP located
in the promoter region of the FSHR gene (c-29G>A; rs1394205)
may cause altered receptor expression (Desai et al., 2011).
It may result in cumulative effects, together with other FSHR,
FSHB and follistatin gene variants (Urbanek et al., 1999),
modulating reproductive parameters (Grigorova et al., 2014;
Simoni and Casarini, 2014). In fact, the SNP -211G>T located
within the FSHB promoter negatively inﬂuences reproduc-
tive parameters in men but not in women, suggesting gender-
speciﬁc regulation of gonadotrophin secretion and, as a
consequence, of progesterone and testosterone production
(Schüring et al., 2012). Indeed the FSHB gene was found to
be associated with PCOS (Hayes et al., 2015). Because of their
role in the modulation of gonadal functions, FSHR common
SNPs are also involved in PCOS pathogenesis in women (Du
et al., 2010; Mutharasan et al., 2013), and are associated with
hyperandrogenic phenotypes (Valkenburg et al., 2009),
preterm birth (Chun et al., 2013) and ovarian cancer risk (Qin
et al., 2014). The same SNPs are linked to testicular germ cell
tumours (Ferlin et al., 2008), and infertility (Shimoda et al.,
2009) in men. Interestingly, FSHR SNPs may be associated with
longevity and lower risk of developing Alzheimer’s disease in
women but not in men (Corbo et al., 2011, 2013), leading to
the speculation that it may have played a role in prolonging
the life span of women.
YAP1 gene
The YES associated protein 1 (YAP1) gene is highly ex-
pressed in placenta, prostate, testis, ovary and small intes-
tine (Sudol et al., 1995). It is a nuclear factor downstream
to the Hippo signalling pathway, involved in anti-apoptotic
processes related to cell fate during development, cell pro-
liferation, DNA repair, homeostasis and oncogenesis (Basu
et al., 2003; Zhang et al., 2011; Fu et al., 2014). YAP1 acts
as an oestrogen and progesterone receptor co-activator
(Dhananjayan et al., 2006), potentially modulating the ac-
tivity of steroid hormones. In the ovary, Hippo signalling
stimulates follicle growth via activation of YAP1 (Hsueh et al.,
2015), and it has been indicated as a possible target for in-
fertility treatments in PCOS or primary ovarian insufﬁciency
affected women (Kawamura et al., 2013). Therefore, YAP1
is a candidate gene for PCOS pathogenesis (Louwers et al.,
2013); in particular, YAP1 SNPs are associated with differ-
ent oral glucose tolerance and LH levels in Han Chinese PCOS
patients (Li et al., 2012), contributing to modulate pheno-
typic features of the disease. On the contrary, no studies have
demonstrated a signiﬁcant role of YAP in the modulation of
reproductive parameters in males, suggesting that this gene
might be involved in sex-dependent regulatory mechanisms
of metabolism and gonadal functions.
RAB5B/SUOX genetic locus
RAB5B is a Rab-GTPase, which regulates membrane trafﬁck-
ing, endocytosis and receptor recycling (Stenmark, 2009). It
was speculated that, in women, this protein contributes to
the establishment of PCOS hyperandrogenic phenotype by
modulating the gonadotropic action via protein kinase B (AKT)
pathway (McAllister et al., 2015). SUOX gene encodes for a
sulphite oxidase (Garrett et al., 1995), and its genetic vari-
ants were mainly associated with sulphite oxidase deﬁ-
ciency (Garrett et al., 1998; Johnson et al., 2002; Kisker et al.,
1997; Seidahmed et al., 2005). The intergenic region RAB5B/
SUOX was reported as a susceptibility locus for type 1 dia-
betes (Wellcome Trust Case Control Consortium, 2007),
suggesting that SNPs within this region may be implicated in
glucose tolerance in women with PCOS (Saxena et al., 2015).
Little, however, is known about the molecular mechanisms
underlying the involvement of this genomic region in the
pathogenesis of the disease.
INSR gene
The insulin receptor (INSR) is fundamental for insulin me-
tabolism and its genetic variants are associated with
hyperandrogenism, insulin resistance, achantosis nigricans,
obesity and anovulation in women with PCOS (Cui et al., 2013;
Grasso et al., 2013; Højlund et al., 2004; Jiang et al., 2011;
Mukherjee et al., 2009; Tucci et al., 2001). It reﬂects the role
of insulin resistance in the modulation of PCOS features (Chen
et al., 2011) and ovarian function (Sirotkin, 2011). Although
testosterone excess is linked to insulin resistance in women
with PCOS (Alpañés et al., 2015; Münzker et al., 2015), high
androgen levels are linked to weight loss in males (Traish,
2014). Moreover, androgen deﬁciency may result in meta-
bolic syndrome in men (Yu et al., 2014). Taken together, an
inverse, sex-dependent relationship between testosterone and
metabolism homeostasis among PCOS women and men has
been suggested (Navarro et al., 2015).
X-linked PCOS phenotypes
Although PCOS is particular to women, an association has been
found between genes within the X chromosome and the
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disease. A candidate locus may be the cytosine-adenine-
guanine (CAG) repeats within the exon 1 of the AR gene, which
confers differential receptor activity and androgen sensitiv-
ity; different lengths of the CAG and GGN repeats (where ‘N’
indicates “any nucleotide”) are present in white women and
Han Chinese women with PCOS compared with healthy con-
trols, resulting in high testosterone levels and metabolic con-
sequences (Hickey et al., 2006; Peng et al., 2014; Schüring
et al., 2012; Skrgatic et al., 2012; Yuan et al., 2015). Other
studies and a meta-analysis, however, failed to ﬁnd such as-
sociation (Zhang et al., 2013), suggesting that several factors
modulate the disease, most likely polygenic regulation of the
trait. GGN and CAG trinucleotide repeats in the AR gene are
more strongly associated with central obesity in white adult
women rather than men (Gustafson et al., 2003), suggesting
a sex-related relationship between androgens and metabo-
lism. In particular, the length of AR CAG repeats is associ-
ated with testosterone levels and fat accumulation in men
(De Naeyer et al., 2014; Fietz et al., 2011; Mouritsen et al.,
2013; Simmons and Roney, 2011; Zitzmann, 2009), provid-
ing a putative evolutionary advantage for men with high an-
drogen levels. This leads to the evolutionary speculation that
testosterone may have played a role in the choice of the male
partner but with a detrimental effect in female progeny that
inherited high androgen sensitivity (Howard, 2001; Roney
et al., 2010).
Clinical features of women with PCOS may also be modu-
lated via X-linked epigenetic modiﬁcation (Hickey et al., 2006),
but further studies should be conducted to better address this
issue.
Evolutionary theories
Several theories attempting to explain the maintenance of
PCOS in humans, rely on the paradox that the disease results
in a sub-fertile female phenotype, which should be evolu-
tionarily disadvantageous (Corbett and Morin-Papunen, 2013).
The concept of “subfertility”, however, requires clariﬁca-
tion. Women with PCOS encounter infertility problems more
frequently than healthy women, at least in a general popu-
lation sample considered within a time window excluding late
fertile age (Koivunen et al., 2008). In fact, the percentage
of women with PCOS who seek assisted reproduction tech-
niques is higher than in the general population (Koivunen et al.,
2008). The overall number of conceived children per woman
seems not to be affected by the disease (Hudecova et al.,
2009), perhaps owing to a higher success rate after ART (Kalra
et al., 2013) and in spite of increased risk of pregnancy com-
plications (Palomba et al., 2015).
As the overall prevalence of PCOS is constant among human
populations worldwide, the disorder seems to be subjected
to balancing selection, suggesting its appearance before the
rise of different human ethnic groups (Azziz et al., 2011). Some
evolutionary advantages may have occurred from PCOS phe-
notypical features, especially hyperandrogenicity and pro-
pensity to high fat storage as energy reserve.
Women characterized by high androgen levels, espe-
cially testosterone, should beneﬁt from increased muscle and
bone strength, useful in ancient hunter gatherer societies
(Azziz et al., 2011; Holte et al., 1994), in spite of subse-
quent decreased fertility and mating success (Abbott et al.,
2002; Kirchengast, 2005). An evolutionary study proposed that
subfertile women may have played an important role as
“allomothers” (Eggers et al., 2007), a phenomenon well de-
scribed in mammals, including primates (Kumar et al., 2005),
helping to raise children and contributing to the kin selec-
tion and human geographical expansion. Moreover, the fetal
exposure to maternal androgens may confer beneﬁt, increas-
ing fat storage during low food conditions (Shaw and Elton,
2008). Finally, a genetic predisposition to functional
hyperandrogenism may be linked to advantageous
proinﬂammatory genotypes conferring protection against in-
fectious diseases (Escobar-Morreale et al., 2005).
Insulin resistance, metabolic thrift, fat storage and type-2
diabetes may be the result of adaptation to starvation, pro-
viding energy supply for ovarian functions and pregnancy (Azziz
et al., 2011; Corbett et al., 2009; Franks et al., 1996; Holte
et al., 1994; Robinson and Johnston, 1995; Shaw and Elton,
2008). Finally, an interesting theory has attempted to explain
the increase of immature follicles in women with PCOS, which
may serve as oocyte reserve for lean times; moreover, the
later menopausal age may have prolonged the reproductive
window in women, providing a “fertility storage” for a longer
period of time (Gleicher and Barad, 2006). As the reproduc-
tive advantage of women with PCOS was recently proposed
to be the higher chance of live birth in the late fertile age
rather than the duration of the reproductive window, this issue
merits further debate (Kalra et al., 2013).
The association between genetic predisposition with later
menopause and higher PCOS risk was recently conﬁrmed by
GWAS, suggesting that balancing selection may have fa-
voured the prolongation of the reproductive window in spite
of subfertile female phenotypes (Day et al., 2015).
All these theories may explain, at least in part, why geno-
types linked to PCOS are still common among human popu-
lations worldwide. A limitation, however, exists: even if PCOS
is a sex-dependent disease, none of the evolutionary theo-
ries mentioned above takes into account the contribution of
the male sex as a carrier of PCOS-related genotypes, neither
do they consider if these genotypes have consequences in
males, including for their reproductive success.
Sexual conﬂict
A sexual conﬂict arises when shared traits have a common
genetic basis but result in opposite reproductive success
between the sexes, leading to a contrasting selection
(Bonduriansky and Chenoweth, 2009; Pennell and Morrow,
2013). An example is given by male facial masculinity: genetic
factors that increase male facial masculinity decrease facial
attractiveness of female relatives, suggesting that the mas-
culine face increases the reproductive success in men but de-
creases the genetic beneﬁts of female offspring (Lee et al.,
2014).
Sexual conﬂict was experimentally measured in non-
humans. In insect models, the optimal balance between re-
production and lifespan is different for the sexes. The best
reproductive success of women is achieved with a longer life
span, whereas men achieve a higher number of reproduc-
tive events in early life at the cost of a reduced life span linked
to the high energetic expenses for mating (Berg and Maklakov,
2012).
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Therefore, selection, in terms of life span, differently in-
ﬂuences the reproductive success of men and women. As sex
hormones regulate reproductive functions, they should be
strong candidates as regulators of sexual conﬂict dynamics.
Indeed, testosterone has a contrasting, sex-related effect on
reproductive success in rodents and birds: high levels of the
hormone were associated with high reproductive success of
men compared with their their daughters, who were chal-
lenged with reproductive problems related to a masculine phe-
notype (Mills et al., 2012; Peterson et al., 2014). Therefore,
the genetic beneﬁts of selecting males with high testoster-
one levels are lost in the opposite-sex progeny.
In response to sexually antagonistic selection, sexual di-
morphism occurred and sex-related phenotypes evolved
seperately. Men have higher testosterone levels, leading to
a sex-speciﬁc hormonal environment, which may be consid-
ered a form of sexual dimorphism (Mokkonen and Crespi,
2015). Nevertheless, it has been hinted that this sexual con-
ﬂict has not been completely solved, and studies aiming at
understanding sexual antagonism in humans and other animals
focused on testosterone are needed (Mills et al., 2009;
Mokkonen et al., 2012).
Sexual conﬂict in PCOS
We suggest that intralocus sexual conﬂict provides an optimal
explanation for the PCOS paradox. It should explain the overall
constant prevalence of the disease among human popula-
tions (Azziz et al., 2011) despite the the loss of PCOS-
related genotypes caused by decreased fecundability and
increased risk of pregnancy and neonatal complications
(Palomba et al., 2015). The hereditary nature of the
hyperandrogenic phenotype was previously suggested. For in-
stance, the connection between PCOS and high levels of serum
androstenedione and dehydroepiandrosterone-sulphate in
women is similar to that between premature baldness and high
testosterone levels among male relatives (Govind et al., 1999).
Increased male androgenicity and fertility caused by short CAG
repeats in the AR gene may represent a locus of antagonis-
tic sexual selection, as the genotype linked to a
hyperandrogenic phenotype may be disadvantageous for
female reproduction (Summers and Crespi, 2008). In fact, the
negative effect of high androgen levels on reproductive func-
tion, psychology and quality of life of females has been
demontrated (Shifren, 2004), despite an evolutionary advan-
tage for men. High androgen levels are linked to aggressive-
ness andmuscular strength (Bardin and Catterall, 1981; Raboch
et al., 1987), which may be useful in improving chances of
success in ﬁnding resources and consequent male survival.
Androgen levels are strictly connected with an opposite
bidirectional modulation of glucose homeostasis in men and
women (Escobar-Morreale et al., 2014), which is linked to
metabolic syndrome, insulin resistance and type 2 diabetes
(Navarro et al., 2015). Different responses to selection of in-
dividual traits, such as weight, total cholesterol and blood
glucose, exist between human males and females (Stearns
et al., 2012), resulting from diverse physiological adapta-
tions to the energetic demand ancestrally required. Even if
lifestyle certainly affects the individual metabolic features
(Ekblom et al., 2015), together with epigenetic causes
(Kong et al., 2009; Smith and Ryckman, 2015), the genetic
background strongly contributes to the development of meta-
bolic syndrome (Aguilar et al., 2015), suggesting a heritable
predisposition. It is reasonable, even if speculative, that high
blood glucose levels and fat storage may serve as energy
reserve to sustain ovarian function, pregnancy and lacta-
tion during periods of food shortage. In contrast, a high body
mass index phenotype may be disadvantageous for men in
hunter gatherer societies, in which athletic performance may
be a determinant to achieving food resources and to avoid-
ing predators (Figure 1). Also, androgen deﬁciency in men
is related to metabolic problems (Buvat et al., 2013), as dem-
onstrated in vitro (Nasiri et al., 2015) and conﬁrmed in AR
gene knock-out mice (Dubois et al., 2015). Moreover, low an-
drogen levels negatively affect male fertility and longevity
(Buvat et al., 2013; Morales, 2011), thereby decreasing the
individual reproductive success. On the contrary, low number
of pregnancies and late-age conceptions, which may be more
frequent in women with high androgen levels, such as in PCOS,
were suggested to positively affect longevity (Laufer, 2015).
According to this theory, the low energy expended for re-
production may be invested in the maintenance of somatic
tissue, resulting in longer life span (Kirkwood and Rose, 1991).
Longevous women should be a social source for taking care
of other relatives’ children, giving an evolutionary and he-
reditable advantage to the group (Hawkes et al., 1998). This
topic is widely debated and opposite opinions raised, re-
cently issued by an interesting series of reviews (Laufer, 2015).
As recently argued (Archer, 2015), the increasing preva-
lence of obesity in the last century, especially in Western
societies, may be worsened by exaggerated maternal ener-
getic resources accumulated by successive generations of
metabolically compromised mothers. It results in the loss of
competition between maternal and fetal energy demand,
which, together with the lack of exercise and the high avail-
ability of food, lead to a high propensity of nutrient seques-
tration in pancreatic beta-cells and adipocytes of children.
THADA gene SNPs may be involved in this process by modu-
lating pancreatic beta-cell function (Simonis-Bik et al., 2010).
The authors reasoned that lack of natural negative selec-
tion occurs also via the increment of caesarean sections, al-
lowing highly “storing-energy” fetuses to be born and
increasing the risk of a metabolic tipping point among the
global population. Moreover, maternal PCOS was associated
with increased risk in the offspring to develop metabolic dis-
orders (Doherty et al., 2015; Welt and Carmina, 2013). Al-
though more studies need to be conducted, this hypothesis
suggests that the lifestyle in “westernized” societies should
compromise the result of metabolic selection occurred during
ancient human evolution.
Contribution of genetic drift
We previously showed the contribution of genetic drift to the
distribution of the PCOS genetic markers worldwide by an in-
silico approach (Casarini and Brigante, 2014). In this evolu-
tionary study, the frequencies of SNPs linked to the disease
from both male and female human samples were analysed,
to ensure that the “male factor” was not lost. The geno-
types linked to the disease were differently represented among
continents, resulting in a peculiar distribution matching the
main geographic areas. The analysis of genetic diversity
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(Holsinger and Weir, 2009), calculated using the frequency
of PCOS markers, revealed an increase together with the dis-
tance from Ethiopia, Africa. As this was assumed to be the
putative starting point of ancient human migration
(Ramachandran et al., 2005), these data support genetic drift.
Interestingly, the heterozygosity calculated using PCOSmarkers
did not decrease, in contrast with the well-known concept
of population genetics by which heterozigosity decreases
during repeated migrations of some individuals moving from
a wider group (Henn et al., 2012; Ramachandran et al., 2005).
This suggests that PCOS markers were subjected to a selec-
tive pressure that affected the decay of heterozygosity, al-
though genetic drift contributed to its qualitative distribution.
Curiously, the disease is constantly prevalent worldwide even
if represented by different genotypes (Corbett and
Morin-Papunen, 2013). Taken together, these results support
the hypothesis that PCOS accompanies humans in their
evolution.
In conclusion, a measure of the inﬂuence of PCOS-related
subfertility on the female reproductive success during human
evolution is not available. The antiquity of PCOS was ascer-
tained by documents from the ancient Greek scientist
Hippocrate, about 2400 years ago, who described sub-
fertile women characterized by masculine appearance
(Hanson, 1975). Therefore, the disease accompanied women
for some time and it is still widespread across continents, even
if linked to subfertile phenotypes. Overall, its effect on female
reproductive success should be better assessed. The mean life
expectancy worldwide was overall less than 40 years until the
beginning of the previous century (Christensen et al., 2009),
because of environmental factors, such as infectious dis-
eases, wars or famines, downsizing the beneﬁt of a long re-
productive window in the past (Casarini et al., 2015). On the
other hand, motherhood attempts should be reasonably high
and constantly repeated during the entire reproductive life
span of women. In such a scenario, what is the contribution
of hyperandrogenic males to the PCOS-related genotype dis-
tribution? Current clinical data, obtained from women with
PCOS undergoing assisted reproducton technqiues (often at
a late, sub-optimal age for pregnancy), pose the disease as
an evolutionary paradox. The presence of genotypes sexu-
ally linked to opposite effects on female and male fertility,
however, may not affect overall human reproductive success,
thus resulting in their heritability and perpetuation through
human evolution.
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